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Expression of the Native Cholera Toxin B Subunit Gene and Assembly as
Functional Oligomers in Transgenic Tobacco Chloroplasts
Abstract
The B subunits of enterotoxigenic Escherichia coli (LTB) and cholera toxin of Vibrio cholerae (CTB) are
candidate vaccine antigens. Integration of an unmodified CTB-coding sequence into chloroplast genomes
(up to 10,000 copies per cell), resulted in the accumulation of up to 4.1% of total soluble tobacco leaf
protein as functional oligomers (410-fold higher expression levels than that of the unmodified LTB gene
expressed via the nuclear genome). However, expresssion levels reported are an underestimation of
actual accumulation of CTB in transgenic chloroplasts, due to aggregation of the oligomeric forms in
unboiled samples similar to the aggregation observed for purified bacterial antigen. PCR and Southern
blot analyses confirmed stable integration of the CTB gene into the chloroplast genome. Western blot
analysis showed that the chloroplast-synthesized CTB assembled into oligomers and were antigenically
identical with purified native CTB. Also, binding assays confirmed that chloroplast- synthesized CTB binds
to the intestinal membrane GM1-ganglioside receptor, indicating correct folding and disulfide bond
formation of CTB pentamers within transgenic chloroplasts. In contrast to stunted nuclear transgenic
plants, chloroplast transgenic plants were morphologically indistinguishable from untransformed plants,
when CTB was constitutively expressed in chloroplasts. Introduced genes were inherited stably in
subsequent generations, as confirmed by PCR and Southern blot analyses. Increased production of an
efficient transmucosal carrier molecule and delivery system, like CTB, in transgenic chloroplasts makes
plant-based oral vaccines and fusion proteins with CTB needing oral administration commercially
feasible. Successful expression of foreign genes in transgenic chromoplasts and availability of markerfree chloroplast transformation techniques augurs well for development of vaccines in edible parts of
transgenic plants. Furthermore, since the quaternary structure of many proteins is essential for their
function, this investigation demonstrates the potential for other foreign multimeric proteins to be properly
expressed and assembled in transgenic chloroplasts.
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The B subunits of enterotoxigenic Escherichia coli (LTB) and cholera toxin of Vibrio cholerae
(CTB) are candidate vaccine antigens. Integration of an unmodified CTB-coding sequence into
chloroplast genomes (up to 10,000 copies per cell), resulted in the accumulation of up to 4.1% of
total soluble tobacco leaf protein as functional oligomers (410-fold higher expression levels than
that of the unmodified LTB gene expressed via the nuclear genome). However, expresssion levels
reported are an underestimation of actual accumulation of CTB in transgenic chloroplasts, due to
aggregation of the oligomeric forms in unboiled samples similar to the aggregation observed for
purified bacterial antigen. PCR and Southern blot analyses confirmed stable integration of the
CTB gene into the chloroplast genome. Western blot analysis showed that the chloroplastsynthesized CTB assembled into oligomers and were antigenically identical with purified native
CTB. Also, binding assays confirmed that chloroplast- synthesized CTB binds to the intestinal
membrane GM1-ganglioside receptor, indicating correct folding and disulfide bond formation of
CTB pentamers within transgenic chloroplasts. In contrast to stunted nuclear transgenic plants,
chloroplast transgenic plants were morphologically indistinguishable from untransformed plants,
when CTB was constitutively expressed in chloroplasts. Introduced genes were inherited stably in
subsequent generations, as confirmed by PCR and Southern blot analyses. Increased production of
an efficient transmucosal carrier molecule and delivery system, like CTB, in transgenic
chloroplasts makes plant-based oral vaccines and fusion proteins with CTB needing oral
administration commercially feasible. Successful expression of foreign genes in transgenic
chromoplasts and availability of marker-free chloroplast transformation techniques augurs well for
development of vaccines in edible parts of transgenic plants. Furthermore, since the quaternary
structure of many proteins is essential for their function, this investigation demonstrates the
potential for other foreign multimeric proteins to be properly expressed and assembled in
transgenic chloroplasts.
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There is currently much enthusiasm for the potential of genetically engineered plants to help
control human and animal diseases, through production of edible vaccines.1,2 Plants
expressing bacterial and viral antigens as nuclear transgenes are capable of triggering
immune responses when the transgenic tissues are administered orally.3–6 Indeed, it has
been suggested that plant cells containing an oral vaccine may actually potentiate vaccine
activity by protecting against premature digestion of the antigen.7 Despite this promise,
transgenes expressed via the nucleus often yield insufficient antigen levels, reported as total
soluble protein (TSP) or fresh weight (FW): B subunits of enterotoxigenic Escherichia coli
(0.01% TSP),3 hepatitis B virus envelope surface protein (0.01% TSP)8,9 (0.01% FW),6,10
human cytomegalovirus glycoprotein B (0.02% TSP),11 and transmissible gastroenteritis
coronavirus glycoprotein S (0.06% TSP).12 Therefore, one ever-present mission is to
increase the level of transgene expression within transgenic plants.7
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Cholera toxin B subunit (CTB) is a candidate oral subunit vaccine for cholera, a disease that
causes acute watery diarrhea by colonizing the small intestine and producing the
enterotoxin, cholera toxin (CT). Cholera toxin is a hexameric AB5 protein consisting of one
toxic 27 kDa A subunit having ADP ribosyl transferase activity and a non-toxic pentamer of
11.6 kDa B subunits that binds to the A subunit and facilitates its entry into the intestinal
epithelial cells. When administered orally, CTB is a potent mucosal immunogen;13 this is
believed to be a result of CTB binding to eukaryotic cell surfaces via GM1 ganglioside
receptors present on the intestinal epithelial surface, eliciting a mucosal immune response to
pathogens and enhancing the immune response when coupled chemically to other
antigens.14,15
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The B subunits of enterotoxigenic E. coli (LTB) and cholera toxin of Vibrio cholerae genes
have been expressed at different levels via the plant nucleus. When the native LTB gene was
expressed via the tobacco nuclear genome, LTB accumulated at levels less than 0.01% of
the total soluble leaf protein.3 To improve LTB expression, a synthetic gene was created that
contained plant-preferred codons and eliminated potential mRNA processing signals and
destabilizing motifs found in the native gene.16 Using the native CTB gene for comparison,
the synthetic gene increased antigen accumulation in leaves and tubers by threefold to 14fold.7,16 However, extensive codon modification of genes is laborious and expensive. One of
the consequences of these constitutively expressed high LTB levels was the stunted growth
of transgenic plants that was eventually overcome by tissue-specific expression in potato
tubers.16 By altering the native CTB gene to code for a C-terminal SEKDEL sequence,
which targets expression to the endoplasmic reticulum, CTB expression of up to 0.3% TSP
was achieved in auxin-induced potato tissues via the nuclear genome.17
Increased expression levels of several proteins have been attained by expressing foreign
proteins in chloroplasts of higher plants.18 – 20 Recently, human somatotropin (7% TSP)21
and antimicrobial peptides (21% TSP)22 have been expressed in transgenic chloroplasts. The
accumulation levels of the Bt Cry2Aa2 operon in tobacco chloroplasts were as high as
46.1% of the total soluble plant protein.23 Besides the ability to express polycistrons,
another advantage of chloroplast transformation is the lack of recombinant protein
expression in pollen of chloroplast transgenic plants.23 Absence of chloroplast DNA in the
pollen of most crops reduces pollen-mediated outcross of transgenes.19–26 Also, stable
incorporation of the CTB gene into spacer regions between functional genes of the
chloroplast genome by homologous recombination eliminates the “position effect”
frequently observed in nuclear transgenic plants. Lack of gene silencing in chloroplasts
should allow uniform expression levels in different transgenic lines. Integration of the
transgene into chloroplast genomes should result in a high level of CTB gene expression,
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since each plant cell contains up to 10,000 copies of the plastid genome.27 Similar to the
endoplasmic reticulum, the production of CTB in chloroplasts allows formation of disulfide
bridges,21,28,29 which are necessary for the correct folding and assembly of the CTB
pentamer.30
Here, we report that integration of the CTB gene into the tobacco chloroplast genome results
in high levels of CTB accumulation and assembly of functional oligomers in chloroplasts.
This eliminates the need to modify the CTB gene for optimal expression in plants.
Furthermore, since the quaternary structure of many proteins is essential for their function,
this investigation demonstrates the potential for other foreign multimeric proteins to be
expressed and assembled properly in the chloroplast.

Results and Discussion
Vector construction and E. coli expression
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The pLD-LH-CTB (Figure 1(a)) vector integrates the genes of interest into the inverted
repeat regions through homologous recombination events between the trnI and trnA
chloroplast border sequences of the transformation vector and the corresponding
homologous sequences of the chloroplast genome. Unique advantages of integration of
foreign genes at this site include accomplishment of homoplasmy in the first round of
selection due to the presence of a complete chloroplast origin of replication within the
flanking sequence31,32 and doubling the copy number of foreign genes per cell. The
chimeric aminoglycoside 3′ adenylyltransferase (aadA) gene, conferring resistance to
spectinomycin and streptomycin, and the CTB gene downstream of it are driven by the
constitutive promoter of the rRNA operon (Prrn), each with individual ribosome-binding
sites (GGAGG), and the foreign transcripts are stabilized by the psbA3′ untranslated region.
Since the protein synthetic machinery of chloroplasts is similar to that of E. coli,33 CTB
expression of the pLD-LH-CTB vector was initially tested in E. coli. Western blot analysis
of sonicated E. coli cell extracts showed the presence of 11 kDa CTB monomers, similar to
commercially available CTB (Figure 2(a)), when blots were probed with rabbit anti-cholera
serum. Oligomeric expression of CTB was not observed in E. coli, as expected, due to the
absence of a leader peptide sequence present in the native CTB gene that normally directs
the CTB monomer into the periplasmic space allowing for concentration and oligomeric
assembly. Inability of E. coli to form disulfide bridges in the cytosol is a major limitation in
large-scale production of this antigen.
Determination of chloroplast integration and homoplasmy
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Five bombardments resulted in 68 independent transformation events. Each transgenic clone
was subjected to a second round of spectinomycin selection and putative chloroplast
transformants were confirmed by PCR screening. Primers were designed to determine
whether the integration of foreign genes had occurred in the chloroplast genome at the
directed site by homologous recombination. The strategy employed was to land one primer
(3P) on the native chloroplast genome adjacent to the point of integration and the second
primer (3M) on the aadA gene (Figure 1(a)). The presence of the 1.65 kb PCR product in
nine out of the ten putative transgenics screened, confirmed the site-specific integration of
the gene cassette into the chloroplast genome (Figure 1(b)). The putative transgenic line 4
(lane 6) is a spontaneous mutant. Such mutations occur in the 16 S rRNA gene and confer
high levels of spectinomycin resistance.34 Nuclear transformants resulting from integration
of the aadA gene downstream of functional promoters do not confer high levels of
spectinomycin resistance and are therefore eliminated in the selection process. To
demonstrate the presence of the CTB gene in the transgenic lines 1–3 and 5–10, an
additional PCR was performed using a primer (5P) that lands upstream of the CTB gene, on
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the aadA gene, and one (2M) that lands downstream of the CTB gene, on the trnA gene
(Figure 1(c)). The presence of the 1.9 kb PCR product from all the transgenic lines analyzed
verifies the expected integration of the CTB gene in tandem with the aadA gene.
Southern blot analysis of three PCR positive transgenic lines (T0) was done to verify sitespecific integration and to establish copy number. In the chloroplast genome, BglII sites
flank the chloroplast border sequences 5′ of 16 S rRNA and 3′ of the trnA region (Figure
3(a)). Either a 6.17 kb or a 4.47 kb fragment from transformed or untransformed plants was
obtained when total plant DNA was digested with BglII. The 32P random primer-labeled
0.81 kb trnI-trnA probe fragment, hybridized with the untransformed control giving a 4.47
kb fragment as expected, while a 6.17 kb fragment was observed for the transgenic lines
(Figure 3(b) and (c)), indicating that all plastid genomes had the gene cassette inserted
between the trnI and trnA regions. The absence of a 4.47 kb fragment in transgenic lines
indicates that homoplasmy has been achieved. Southern blot confirmed that plants
transferred to pots were seen to have no adverse pleiotropic effects compared to
untransformed plants (Figure 4(a)). Southern blot analysis of T1 plants (Figure 3(c)) shows
that all four transgenic lines analyzed maintained homoplasmy.
Immunoblot analysis of chloroplast-synthesized CTB
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Anti-cholera toxin antibodies showed no significant cross-reaction with tobacco plant
protein (Figure 2(b), lane 1). In unboiled samples, chloroplast-synthesized CTB appeared as
oligomers (Figure 2(c), lane 4) similar to the unboiled, pentameric bacterial CTB, which
appeared to have partially dissociated into tetramers, trimers and monomers upon storage at
4 °C over a period of several months (Figure 2(c), lane 7). The absence of monomers in
transgenic plant extracts suggests that unassembled monomers are proteolytically degraded.
While heat treatment (four minutes, boiling), prior to SDS-PAGE, of pentameric bacterial
CTB gave CTB monomeric and multimeric forms (Figure 2(c), lane 6), chloroplastsynthesized CTB dissociated into dimers, trimers and multimers when subjected to similar
heat treatment (Figure 2(c), lanes 3 and 5). This is not due to inadequate boiling or low
concentrations of dithiothreitol or β-mercaptoethanol. Increasing these agents to reduce
disulfide bridges or increasing duration of boiling did not alter polypeptide profiles
significantly. However, the same conditions were adequate to dissociate bacterial pentamers
(Figure 2(c), lane 6). These results differ from the heat-induced dissociation of potato plant
nuclear-synthesized CTB oligomers into monomers.17 A probable reason for this unusual
stability could be a more stable conformation of chloroplast-synthesized CTB, which may be
an added advantage in storage and administration of edible vaccines. Proteins larger than 55
kDa are aggregates of oligomers in plant extracts and purified bacterial antigen (Figure 2(c),
lanes 4 and 7). Because of variations in the degree of aggregation, boiled samples did not
show identical polypeptide profiles. Leaf homogenates from four different transgenic lines
showed similar expression levels of CTB protein (Figure 2(b), lanes 3–6) due to lack of gene
silencing or position effect that are usually observed in nuclear transgenic plants. This
confirms that clonal variation of CTB expression is minimal among independent transgenic
lines, as observed in ELISA quantification assays. Consistent expression levels of
recombinant proteins in plants (as obtained for CTB in this research) may be essential for
production of edible vaccines in plants.
ELISA quantification of CTB expression
Both transgenic T0 lines tested yielded CTB protein levels ranging between 3.5% and 4.1%
of the total soluble protein (40 µg of chloroplast-synthesized CTB protein in 1 mg of total
soluble protein, Figure 5(a)). Aggregation of assembled pentamers (Figure 2(c), lane 4) in
plant extracts similar to purified bacterial antigen (Figure 2(c), lane 7) should have resulted
in underestimation of CTB in ELISA, where protein extracts were used directly without any
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treatment to dissociate aggregated CTB. This inference is supported by observation of very
high levels of bacterial genes (up to 46% TSP) with similar AT content in transgenic
chloroplasts.22,23 Also, estimation of CTB expression levels from different stages of leaves
(young, mature and old) determined that mature leaves have the highest levels of CTB
protein expression. The top three or four leaves were designated as young; large, welldeveloped leaves collected from the middle of the plant were considered as mature; leaves
that were generally bleached or undergoing scenescence, from the bottom of the plant were
designated as old. This observation is in accordance with the results obtained when similar
experiments were performed with the Bt Cry2aA2 gene, expressed as a single gene.23
However, when this gene was expressed with a putative chaperonin gene as the Cry2aA2
operon, high expression levels in older leaves were observed, probably due to the formation
of stable crystalline structure.23
GM1-ganglioside ELISA binding assays
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Both chloroplast-synthesized and bacterial CTB demonstrated a strong affinity for GM1ganglioside (Figure 5(b)), indicating that chloroplast-synthesized CTB conserved the
antigenic sites necessary for binding of the CTB pentamer to the pentasaccharide GM1. The
GM1 binding ability also suggests proper folding of CTB molecules resulting in the
functional pentameric structure. Since oxidation of cysteine residues in the B subunits is a
prerequisite for in vivo formation of CTB pentamers,30 proper folding is a further
confirmation of the ability of chloroplasts to form disulfide bonds. The ratio of CTB
expression in transgenic lines 3 (3.5 %) and 7 (4.1 %) in the CTB quantitative assay (Figure
5(a)) is proportional to the GM1 binding measured absorbance ratio of transgenic lines 3 (A
= 1.2) and 7 (A = 1.4; Figure 5(b)). This observation indicates that the binding of CTB to
GM1 is proportional to the level of synthesis in two different transgenic lines.
High levels of constitutive expression of CTB in transgenic tobacco did not affect growth
rates, flowering or seed setting, unlike previous reports for the synthetic LTB gene,
constitutively expressed via the nuclear genome.16 Therefore, there is no need to regulate
CTB expression in transgenic chloroplasts or express it in specific tissues to overcome
pleiotropic effects. Transformed plant seedlings were green, while untransformed seedlings
lacking the aadA gene were bleached white (Figure 4(b)) when germinated on
spectinomycin-containing medium.
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The potential use of the chloroplast technology developed in this study is threefold. It can be
used for (1) large-scale production of purified CTB, (2) as an edible vaccine if expressed in
an edible plant or (3) as a fusion transmucosal carrier peptide, to either enhance mucosal
immunity or induce oral tolerance to the products of these peptides.14 Large-scale
production of purified CTB in bacteria involves the use of expensive fermentation
techniques and stringent purification protocols,35 making this a prohibitively expensive
technology for developing countries. The cost of producing 1 kg of recombinant protein in
transgenic crops has been estimated to be 50 times lower than the cost of producing the
same amount by E. coli fermentation.36 If 5% of the alfalfa soluble protein were the target
protein, one could harvest about 15 kg of the transgenic-expressed protein/acre per year.37
While existing expression levels of CTB via the chloroplast genome are adequate for
commercial exploitation, levels could be increased further (up to 50% total soluble protein)
by insertion of a putative chaperonin,23 which may also aid in the subsequent purification of
recombinant CTB due to crystallization. If used as an edible vaccine, a selection scheme
eliminating the use of antibiotic-resistance genes should be developed.38 One such scheme
uses the betaine aldehyde dehydogenase (BADH) gene, which converts toxic betaine
aldehyde to non-toxic glycine betaine, an osmoprotectant.39 Other strategies have been
developed to eliminate antibiotic-resistance genes from transgenic plants.40 Development of
edible vaccines in transgenic leaves are ideal for animal vaccines. Future development of
J Mol Biol. Author manuscript; available in PMC 2012 October 17.
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edible vaccines for human consumption would be more appealing if the vaccines were
expressed in edible parts of transgenic plants. Expression of a transgene in chromoplasts has
been demonstrated,41,42 and the efficiency of translation of foreign genes in chromoplasts is
similar to that of chloroplasts.43 Therefore, we anticipate that elevated edible vaccine
expression in chromoplasts of transgenic fruits is both feasible and forthcoming.

Materials and Methods
Construction of the chloroplast expression vector pLD-LH-CTB
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Primers were designed to introduce an RBS site (GGAGG) five bases upstream of the start
codon of the coding sequence of the native CTB gene, and the leader peptide sequence was
deleted. The PCR product was cloned into the multiple cloning site of the pCR2.1 vector
(Invitrogen) and subsequently cloned into the chloroplast expression vector pLD-CtV2 after
verification of the correct DNA sequence. E. coli (transformed by standard CaCl2
transformation procedure) and untransformed E. coli cultures (24 and 48 hours) were
centrifuged (ten minutes at 10,000 g), the pellets were washed twice with 200 mM Tris-HCl,
resuspended in 500 µl of extraction buffer (200 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10
mM EDTA, 2 mM PMSF) and sonicated. Double-strength SDS sample buffer was added to
100 µl of transformed and untransformed sonicates (containing 50– 100 µg of crude protein
extract as determined by Bradford protein assay (Bio Rad)) and purified CTB (100 ng,
Sigma). These samples were loaded onto an SDS-15%/PAGE gel and electrophoresed at 200
V for 45 minutes. The separated protein was transferred to a nitrocellulose membrane by
electroblotting at 70 V for 90 minutes.
Immunoblot analysis of CTB production in E. coli
Blocking by incubation of the membrane in 25 ml of 5% (w/v) non-fat dry milk in TBS
buffer (20 mM Tris base (Fisher), 500 mM NaCl (Sigma), pH 7.5) for two hours on a rotary
shaker was followed by washing in TBS buffer. Incubation for one hour in a 1:5000 dilution
of rabbit anti-cholera antiserum (Sigma) in TBST (TBS buffer with 0.05% (v/v) Tween-20)
containing 1% non-fat dry milk and washing thrice in TBST buffer was followed by
incubation in a 1:10,000 dilution of alkaline phosphatase conjugated mouse anti-rabbit IgG
(Sigma) in TBST. The membrane was washed thrice in TBST, once with TBS followed by
incubation in alkaline phosphatase color development reagents, BCIP/NBT in AP color
development buffer (Bio Rad) for an hour.
Bombardment and regeneration of chloroplast transgenic plants
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Microprojectiles coated with plasmid DNA (pLD-LH-CTB) were bombarded into Nicotiana
tabacum var. Petit havana leaves using the biolistic device PDS1000/He (Bio Rad), as
described by Daniell.44 Following incubation at 24 °C in the dark for two days, the leaves
were cut into small (~5 mm × 5 mm) pieces and placed abaxial side up (five pieces/plate) on
selection medium (RMOP containing 500 mg/l spectinomycin dihydrochloride).
Spectinomycin-resistant shoots obtained after about six weeks were cut into small pieces (~2
mm × 2 mm) and placed onto plates containing the same selection medium.
PCR analysis
Total plant DNA from putative transgenic and untransformed plants was isolated using the
DNeasy kit (Qiagen). PCR primers, AAAACCCGTCCTCAGTTCGGATTGC (3P),
CCGCGTTGTTTCATCAAGCCTTACG (3M), CTGTAGAAGTCACCATTGTTGTGC
(5P), and TGACTGCCCACCTGAGAGCGGACA (2M) were used to perform PCR on both
putative transgenic and untransformed plant total DNA. After denaturation for five minutes
at 94 °C, samples were carried through 30 cycles using the following temperature sequence:
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94 °C for one minute, 62 °C for 1.5 minutes and 72 °C for two minutes. PCR confirmed
shoots, from the second culture cycle, were transferred to rooting medium (MSO medium
containing 500 mg/l spectinomycin).
Southern blot analysis
Ten micrograms of plant DNA per sample (isolated using DNeasy kit) digested with BglII,
were separated on a 0.7% (w/v) agarose gel and transferred to a nylon membrane. The
chloroplast vector DNA digested with BglII and BamHI generated a 0.8 kb probe
homologous to the flanking sequences. Hybridization was performed using the Ready To Go
protocol (Pharmacia). After Southern blot confirmation, plants were transferred to soil.
Upon flowering, seeds were germinated on spectinomycin dihydrochloride selection
medium. The T1 seedlings were grown in bottles containing MSO with spectinomycin (500
mg/l) for two weeks, and plants were transferred to pots.
Western blot analysis of plant protein
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Transformed and untransformed leaves (100 mg) were ground in liquid nitrogen and
resuspended in 500 µl of extraction buffer (200 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10
mM EDTA, 2 mM PMSF). Leaf extracts (100–120 µg as determined by Lowry assay),
boiled (four minutes) or unboiled, in sample buffer (Bio Rad) were electrophoresed in a 12%
(w/v) polyacrylamide gel for five hours at 200 V. The separated proteins were transferred to
a nitrocellulose membrane by electroblotting at 85 V for one hour. The immunoblot
detection procedure was similar to that done for E. coli blots described above. For the
chemiluminescent detection, the S. Tag™ P Lumiblot kit (Novagen) was used.
ELISA quantification of CTB
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Leaves (transformed and untransformed plants, 100 mg) ground in liquid nitrogen and
resuspended in bicarbonate buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) were bound
to a 96 well polyvinyl chloride microtiter plate (Costar) overnight at 4 °C. Background was
blocked with 1% (w/v) bovine serum albumin (BSA) in 0.01 M phosphate-buffered saline
(PBS) for two hours at 37 °C, washed thrice with washing buffer, PBST (PBS containing
0.05% Tween 20) and rabbit anti-cholera serum diluted 1:8000 in 0.01 M PBST containing
0.5% BSA was added and incubated for two hours at 37 °C. The wells were washed and
incubated with 1:50,000 mouse anti rabbit IgG-alkaline phosphatase conjugate in 0.01 M
PBST containing 0.5% BSA for two hours at 37 °C. Plates were developed with Sigma Fast
pNPP substrate (Sigma). The reaction was ended by addition of 3 M NaOH and plates were
read at 405 nm. Comparison of the absorbance at 405 nm of a known amount of bacterial
CTB-antibody complex (linear standard curve) and that of a known concentration of
transformed plant total soluble protein was used to estimate CTB expression levels.
GM1-ganglioside binding assay
The microtiter plate was coated with monosialogan-glioside-GM1 (Sigma) (3.0 µg/ml in
bicarbonate buffer) and incubated at 4 °C overnight. As a control, BSA (3.0 µg/ml in
bicarbonate buffer) was coated in some wells. The wells were blocked with 1% BSA in
PBS, washed thrice with PBST and incubated with soluble protein from transformed and
untransformed plants, and bacterial CTB in PBS. Incubation of plates with primary and
secondary antibody dilutions and detection was done similar to the CTB ELISA procedure
described above.
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TSP

total soluble protein

FW

fresh weight

CTB

cholera toxin B subunit

LTB

B subunit of enterotoxigenic E. coli

MSO

plant growth medium

RMOP

plant shooting medium
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Figure 1.

Transformed chloroplast genome and PCR analysis of control and chloroplast transformants.
(a) Chloroplast genome after homologous recombination with the pLD-LH-CTB vector.
Flanking sequences involved in recombination are indicated in white. Primer 3P lands on the
native chloroplast genome and 3M lands on the aadA gene, generating a 1.65 kb fragment.
Primer 5P lands on the aadA gene and 2M lands on the trnA flanking sequence, generating a
1.9 kb fragment. (b) PCR analysis: primers 3P 3M generated PCR products using total plant
DNA as template. Lane 1, molecular mass marker; lane 2, untransformed plant; lanes 3–12,
PCR products with DNA template from independent transgenic lines 1–10. (c) PCR
analysis: primers 5P 2M generated PCR products using total plant DNA as template. Lane 1,
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untransformed plant; lane 2, molecular mass marker; lanes 3–5, PCR products with DNA
template from independent transgenic lines 1–3 and 5–10, lanes 3–11.
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Figure 2.

Western blot analysis of CTB expression in E. coli and transgenic chloroplasts. Blots were
detected using rabbit anti-cholera serum as the primary antibody and alkaline phosphatase
labeled mouse anti-rabbit IgG as the secondary antibody. (a) E. coli protein analysis:
purified bacterial CTB (100 ng), boiled (lane 1); unboiled 24 hours and 48 hours
transformed (lanes 2 and 4) and untransformed (lanes 3 and 5) E. coli cell extracts. (b) Plant
protein analysis: color development detection. Boiled, untransformed plant proteins (lane 1);
boiled, purified CTB antigen (100 ng, lane 2); boiled, proteins from four different transgenic
lines (lanes 3–6); molecular mass markers (lane 7). (c) Chemiluminescent detection: Plant
proteins: untransformed, unboiled (lane 1); untransformed, boiled (lane 2); transgenic lines 3
J Mol Biol. Author manuscript; available in PMC 2012 October 17.

Daniell et al.

Page 14

and 7, boiled (lanes 3 and 5); transgenic line 3, unboiled (lane 4); purified CTB antigen (100
ng), boiled (lane 6); purified CTB antigen (100 ng), unboiled (lane 7).
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Figure 3.

Southern blot analysis of T0 and T1 transgenic plants. (a) A representation of untransformed
and transformed chloroplast genomes. Plant DNA was digested with BglII and hybridized
with the 0.81 kb probe, which contained the chloroplast flanking sequences used for
homologous recombination. Untransformed control plant chloroplast genomes should
generate a 4.47 kb fragment and transformed plant chloroplast genomes should generate a
6.17 kb fragment. Southern blot results of (b) T0 lines untransformed Petit Havana (lane 1);
transgenic plants (lanes 2–4); and (c) T1 lines transgenic plants (lanes 1–4) and
untransformed Petit Havana (lane 5). P is the 16 S rRNA promotor and T is the psbA 3′
UTR.
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Figure 4.

(a) Plant phenotypes: 1, confirmed transgenic line 7; 2, untransformed Petit Havana. (b)
Seedlings (ten day-old) of T1 transgenic (1, 2 and 3) and untransformed plant (4) plated on
500 mg/l spectinomycin selection medium.
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Figure 5.

(a) CTB ELISA quantification: absorbance of CTB-antibody complex in known
concentrations of total soluble plant protein was compared to absorbance of known
concentration of bacterial CTB-antibody complex and the amount of CTB was expressed as
a percentage of the total soluble plant protein. Total soluble plant protein from young,
mature and old leaves of transgenic lines 3 and 7 was quantified. (b) CTB-GM1-ganglioside
binding ELISA assays. Plates, coated first with GM1-gangliosides and BSA, respectively,
were plated with total soluble plant protein from transgenic lines 3 and 7, untransformed
plant total soluble protein and 300 ng of purified bacterial CTB. The absorbance of the
GM1-ganglioside-CTB-antibody complex in each case was measured.
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